Overview
Helen Parker practices practicing medicine in Southampton, United Kingdom.
Ms. Parker is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A), Marginal Zone Lymphoma (MZL), Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), and Chronic Lymphocytic Leukemia (CLL).
She is actively involved in clinical research, co-authoring 68 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Helen L. Parker
Is Helen L. Parker a top-rated expert for Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A)?
MediFind is an objective health platform that identifies experts based on real-world data. Helen L. Parker is classified as an Distinguished expert for Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Helen L. Parker participate in research or clinical trials?
Yes. Helen L. Parker has published 68 articles and abstracts on conditions like Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A). You can view a list of Helen L. Parker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Ms. Parker isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Marginal Zone Lymphoma (MZL)Ms. Parker isDistinguished. Learn about Marginal Zone Lymphoma (MZL).
- Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)
- Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A)
- Advanced
- Chronic B-Cell Leukemia (CBCL)Ms. Parker isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- LeukemiaMs. Parker isAdvanced. Learn about Leukemia.
- Mucopolysaccharidoses (MPS)Ms. Parker isAdvanced. Learn about Mucopolysaccharidoses (MPS).
- Small Lymphocytic Lymphoma (SLL)Ms. Parker isAdvanced. Learn about Small Lymphocytic Lymphoma (SLL).
- Splenic NeoplasmMs. Parker isAdvanced. Learn about Splenic Neoplasm.
- Experienced
- B-Cell LymphomaMs. Parker isExperienced. Learn about B-Cell Lymphoma.
- Gastroesophageal Reflux Disease (GERD)Ms. Parker isExperienced. Learn about Gastroesophageal Reflux Disease (GERD).
- GastroparesisMs. Parker isExperienced. Learn about Gastroparesis.
- IndigestionMs. Parker isExperienced. Learn about Indigestion.
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Mucopolysaccharidosis Type 3B (MPS IIIB, Sanfilippo Syndrome B)
- Non-Hodgkin LymphomaMs. Parker isExperienced. Learn about Non-Hodgkin Lymphoma.
- Prolymphocytic LeukemiaMs. Parker isExperienced. Learn about Prolymphocytic Leukemia.